# Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers

> **NCT00470041** · PHASE1 · COMPLETED · sponsor: **University Ghent** · enrollment: 12 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** administration of two anti-viral drugs (lamivudine and zidovudine) from a new oral formulation

## Key facts

- **NCT ID:** NCT00470041
- **Lead sponsor:** University Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470041, "Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00470041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*